Michael Gilbertson

Medtronic (United States) — United States

Medicine · Health Sciences

14h-index1.0kcitations70works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(46), CNS Lymphoma Diagnosis and Treatment(18), Viral-associated cancers and disorders(13), CAR-T cell therapy research(11), Chronic Lymphocytic Leukemia Research(10)

Publications70 total

T-cell immune profile changes predict durable response to nivolumab-rituximab in treatment-naïve FL
Blood Neoplasia·2025Open Access
Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)
American Journal of Respiratory and Critical Care Medicine·2025· 3 citedOpen Access
130 | TISLELIZUMAB, AN ANTI‐PD‐1 ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: FINAL ANALYSIS FROM THE LYSA PHASE 2 TIRHOL STUDY BGB‐A317‐210
Hematological Oncology·2025Open Access
23 | RADIOTHERAPY IMPROVES PROGRESSION‐FREE SURVIVAL FOR STAGE IA NLPHL: A RETROSPECTIVE REPORT FROM THE GLOBAL NLPHL ONE WORKING GROUP (GLOW)
Hematological Oncology·2025Open Access
REDUCING HYPERTENSIVE URGENCY THROUGH RADIOFREQUENCY RENAL DENERVATION: INSIGHTS FROM SPYRAL HTN-OFF AND -ON MED TRIALS
Journal of Hypertension·2025
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach
Internal Medicine Journal·2025· 1 citedOpen Access
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study
Blood Advances·2025· 1 citedOpen Access
PD23 Economic Evaluation Of Prophylactic Immunoglobulin Versus Prophylactic Antibiotics In Hematological Malignancies: Results From The RATIONAL Feasibility Trial
International Journal of Technology Assessment in Health Care·2024Open Access
Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies
Pathology·2024· 6 cited
T Cell CD62L Expression Following Nivolumab Therapy Is Associated with Long Term Response to Rituximab-Nivolumab in Treatment Naïve Follicular Lymphoma: Results from the 1st FLOR Study
Blood·2024Open Access
Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
eJHaem·2024· 4 citedOpen Access
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy
Blood Advances·2024· 11 citedOpen Access
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
Journal of Clinical Oncology·2024· 14 cited
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
Blood Advances·2024· 6 citedOpen Access
Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries
Blood·2023· 1 citedOpen Access
Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain
Blood·2023· 2 cited
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
Journal of Clinical Oncology·2023· 42 citedOpen Access
P1230: T CELL CD62L EXPRESSION FOLLOWING NIVOLUMAB THERAPY IS ASSOCIATED WITH LONG TERM RESPONSE TO RITUXIMAB-NIVOLUMAB IN TREATMENT NAÏVE FOLLICULAR LYMPHOMA: RESULTS FROM THE 1ST FLOR STUDY
HemaSphere·2023Open Access
T cell CD62L expression following nivolumab therapy is associated with response to rituximab‐nivolumab in treatment naïve follicular lymphoma: the 1st FLOR study
Hematological Oncology·2023Open Access
Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance
British Journal of Haematology·2023· 8 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Stephen Opat(23), Eliza A. Hawkes(17), Chan Y. Cheah(15), Gareth P. Gregory(12), George Grigoriadis(11), Jake Shortt(10), Pasquale L. Fedele(9), Matthew Ku(9), Sumita Ratnasingam(9), Kerry J. Savage(8), Dipti Talaulikar(8), Diego Villa(7), Constantine S. Tam(7), Kate Manos(7), Nada Hamad(7), Zoe McQuilten(7), Tara Cochrane(7), Matthew J. Maurer(6), John F. Seymour(6), David Ritchie(6)